Statistics for Eledon Pharmaceuticals, (id:5885 ELDN)
Valuation metrics
Market cap
246.72M
Enterprise value
169.03M
Trailing P/E (ttm)
9.18
Forward P/E
-3.44
PEG ratio
-3.44
Price/Sales (ttm)
Price/Book (mrq)
2.24
Enterprise Value/Revenue
Enterprise Value/EBITDA
5.03
Overview
Shares outstanding
59.74M
Float
46.29M
Shares short
960.55K
% Held by insiders
0.00%
% Held by institutions
0.44%
Average volume (10 days)
445.20K
Average volume (90 days)
Price summary
52-Week low
1.11
52-Week high
5.54
52-Week change
70.57%
Beta
0.77
50-Day moving average
3.20
200-Day moving average
2.55
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
October 05th, 2020
Ex-dividend date
Last split factor
2:1
Last split date
October 05th, 2020
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-33.36%
Return on equity
-25.36%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
33.58M
Net income to common (ttm)
-21,223,000.00
Diluted EPS (ttm)
0.45
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
78.19M
Total cash per share (mrq)
1.31
Total debt (mrq)
501.00K
Total Debt/Equity (mrq)
0.66
Current ratio (mrq)
652.60%
Book value per share (mrq)
1.85
Cash flow
Cash flow statement
-37,415,000.00
Levered free cash flow (LFCF)
-23,197,876.00